AU2001262741A1 - Medicines for the prevention and treatment of neurodegenerative diseases - Google Patents
Medicines for the prevention and treatment of neurodegenerative diseasesInfo
- Publication number
- AU2001262741A1 AU2001262741A1 AU2001262741A AU2001262741A AU2001262741A1 AU 2001262741 A1 AU2001262741 A1 AU 2001262741A1 AU 2001262741 A AU2001262741 A AU 2001262741A AU 2001262741 A AU2001262741 A AU 2001262741A AU 2001262741 A1 AU2001262741 A1 AU 2001262741A1
- Authority
- AU
- Australia
- Prior art keywords
- medicines
- prevention
- treatment
- neurodegenerative diseases
- neurodegenerative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010053643 Neurodegenerative disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drugs Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-185814 | 2000-06-21 | ||
| JP2000185814 | 2000-06-21 | ||
| PCT/JP2001/004934 WO2001098300A1 (en) | 2000-06-21 | 2001-06-12 | Medicines for the prevention and treatment of neurodegenerative diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2001262741A1 true AU2001262741A1 (en) | 2002-03-21 |
| AU2001262741B2 AU2001262741B2 (en) | 2005-07-07 |
Family
ID=18686074
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001262741A Ceased AU2001262741B2 (en) | 2000-06-21 | 2001-06-12 | Medicines for the prevention and treatment of neurodegenerative diseases |
| AU6274101A Pending AU6274101A (en) | 2000-06-21 | 2001-06-12 | Medicines for the prevention and treatment of neurodegenerative diseases |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU6274101A Pending AU6274101A (en) | 2000-06-21 | 2001-06-12 | Medicines for the prevention and treatment of neurodegenerative diseases |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6743803B2 (en) |
| EP (1) | EP1295883A4 (en) |
| KR (1) | KR20030010740A (en) |
| CN (1) | CN100354274C (en) |
| AU (2) | AU2001262741B2 (en) |
| BR (1) | BR0111799A (en) |
| CA (1) | CA2412199A1 (en) |
| CZ (1) | CZ20024153A3 (en) |
| EE (1) | EE04941B1 (en) |
| HU (1) | HUP0301319A3 (en) |
| IL (2) | IL153439A0 (en) |
| MX (1) | MXPA02012599A (en) |
| NO (1) | NO20026148L (en) |
| NZ (1) | NZ523189A (en) |
| PL (1) | PL200537B1 (en) |
| RU (1) | RU2258506C2 (en) |
| SK (1) | SK17682002A3 (en) |
| TW (1) | TWI298068B (en) |
| WO (1) | WO2001098300A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6822097B1 (en) | 2002-02-07 | 2004-11-23 | Amgen, Inc. | Compounds and methods of uses |
| TW200533371A (en) * | 2004-04-15 | 2005-10-16 | Dainippon Pharmaceutical Co | Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative |
| EP1595881A1 (en) | 2004-05-12 | 2005-11-16 | Pfizer Limited | Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands |
| WO2010002451A1 (en) * | 2008-07-01 | 2010-01-07 | Concert Pharmaceuticals, Inc. | Naphthyridin derivatives |
| JP6551671B2 (en) * | 2015-08-11 | 2019-07-31 | 国立大学法人 熊本大学 | Alzheimer's treatment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2683818B1 (en) | 1991-11-14 | 1993-12-31 | Adir Cie | NOVEL 3-SULFONYLAMINO-2- (1H) -QUINOLEINONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| JPH09291034A (en) * | 1996-02-27 | 1997-11-11 | Yoshitomi Pharmaceut Ind Ltd | Condensed pyridine compound and its use as medicine |
| ZA985870B (en) | 1997-07-15 | 1999-01-27 | Dainippon Pharmaceutical Co | 5-substituted-3-oxadiazolyl-1, 6-naphthyridin-2(1H)-one derivatives |
| AR013184A1 (en) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | SPYROZOBICYCLIC HETERO CYCLIC AMINES, PHARMACEUTICAL COMPOSITION, USE OF SUCH AMINES TO PREPARE MEDICINES AND METHOD OF TREATMENT OR PROPHYLAXIS |
| CN1361768A (en) | 1999-06-02 | 2002-07-31 | Nps药物有限公司 | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
-
2001
- 2001-06-06 TW TW090113656A patent/TWI298068B/en not_active IP Right Cessation
- 2001-06-12 RU RU2003101405/04A patent/RU2258506C2/en not_active IP Right Cessation
- 2001-06-12 IL IL15343901A patent/IL153439A0/en active IP Right Grant
- 2001-06-12 SK SK1768-2002A patent/SK17682002A3/en unknown
- 2001-06-12 US US10/311,932 patent/US6743803B2/en not_active Expired - Fee Related
- 2001-06-12 CZ CZ20024153A patent/CZ20024153A3/en unknown
- 2001-06-12 EP EP01936958A patent/EP1295883A4/en not_active Withdrawn
- 2001-06-12 AU AU2001262741A patent/AU2001262741B2/en not_active Ceased
- 2001-06-12 CA CA002412199A patent/CA2412199A1/en not_active Abandoned
- 2001-06-12 MX MXPA02012599A patent/MXPA02012599A/en active IP Right Grant
- 2001-06-12 BR BR0111799-8A patent/BR0111799A/en not_active Application Discontinuation
- 2001-06-12 CN CNB018142834A patent/CN100354274C/en not_active Expired - Fee Related
- 2001-06-12 EE EEP200200698A patent/EE04941B1/en not_active IP Right Cessation
- 2001-06-12 NZ NZ523189A patent/NZ523189A/en unknown
- 2001-06-12 AU AU6274101A patent/AU6274101A/en active Pending
- 2001-06-12 WO PCT/JP2001/004934 patent/WO2001098300A1/en active IP Right Grant
- 2001-06-12 KR KR1020027017221A patent/KR20030010740A/en not_active Application Discontinuation
- 2001-06-12 HU HU0301319A patent/HUP0301319A3/en unknown
- 2001-06-12 PL PL363869A patent/PL200537B1/en not_active IP Right Cessation
-
2002
- 2002-12-15 IL IL153439A patent/IL153439A/en not_active IP Right Cessation
- 2002-12-20 NO NO20026148A patent/NO20026148L/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002213357A1 (en) | Variant igg3 rituxan r and therapeutic use thereof | |
| IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
| EP1399171A4 (en) | Medicinal herbal compounds for the prevention and treatment of diabetes | |
| HUP0301815A3 (en) | Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment | |
| AU2001247331A1 (en) | Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders | |
| IL150742A0 (en) | Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease | |
| WO2001078781A8 (en) | Methods for prevention and treatment of gastrointestinal disorders | |
| AU2002239491A1 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
| AU2002210385A1 (en) | Furazanyl-triazole derivates for the treatment of diseases | |
| AU2002312897A1 (en) | Drugs for the treatment of the alzheimer disease | |
| AU1509999A (en) | Herbal drug composition for the prevention and treatment of dementia | |
| AU2001256855A1 (en) | Preparation for the prevention and treatment of ocular disorders | |
| AU2002247973A1 (en) | Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases | |
| AUPQ344799A0 (en) | Treatment of respiratory diseases and infections | |
| AU2002349268A1 (en) | Medicine for preventing and treating bromidrosis | |
| AU7601400A (en) | Treatment and prevention of hepatic disorders | |
| AU2002325169A1 (en) | Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases | |
| AU4215499A (en) | Treatment of neurodegenerative diseases | |
| AU2001262741A1 (en) | Medicines for the prevention and treatment of neurodegenerative diseases | |
| AU6274101A (en) | Medicines for the prevention and treatment of neurodegenerative diseases | |
| AU2003213898A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
| AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
| AU2002210286A1 (en) | Medicine intended for treatment of multiple sclerosis | |
| AU1405001A (en) | Treatment of diseases | |
| AU2002222125A1 (en) | Prevention and treatment of tachyphylactic response |